Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Femasys Inc (FEMY)

Femasys Inc (FEMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,718
  • Shares Outstanding, K 25,551
  • Annual Sales, $ 1,630 K
  • Annual Income, $ -18,820 K
  • EBIT $ -19 M
  • EBITDA $ -19 M
  • 60-Month Beta -2.62
  • Price/Sales 13.33
  • Price/Cash Flow N/A
  • Price/Book 12.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.91
  • Most Recent Earnings $-0.23 on 05/08/25
  • Next Earnings Date 08/14/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.18
  • Number of Estimates 1
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6930 +22.66%
on 06/04/25
1.0900 -22.02%
on 05/21/25
-0.2300 (-21.30%)
since 05/20/25
3-Month
0.6930 +22.66%
on 06/04/25
1.6999 -50.00%
on 03/21/25
-0.7500 (-46.88%)
since 03/20/25
52-Week
0.6930 +22.66%
on 06/04/25
1.8000 -52.78%
on 02/21/25
-0.4200 (-33.07%)
since 06/20/24

Most Recent Stories

More News
Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth

FEMY : 0.8500 (-3.41%)
Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations

FEMY : 0.8500 (-3.41%)
Femasys Announces Pricing of Underwritten Public Offering and Concurrent Private Placement with Gross Proceeds of $4.5 Million

FEMY : 0.8500 (-3.41%)
Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

FEMY : 0.8500 (-3.41%)
Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update

FEMY : 0.8500 (-3.41%)
Femasys Reports Wider-Than-Expected Annual Loss, But Retail Continues To Be Optimistic

The company said that as of the end of 2024, it had an accumulated deficit of $127.2 million and cash and cash equivalents of only $3.5 million.

VXF : 186.68 (-0.29%)
VTI : 293.43 (-0.23%)
FEMY : 0.8500 (-3.41%)
Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update

FEMY : 0.8500 (-3.41%)
Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations

FEMY : 0.8500 (-3.41%)
Q1 Virtual Investor Summit: On-Demand Presentations Now Live

NEW YORK, NY / ACCESS Newswire / March 18, 2025 / The Investor Summit is excited to announce that presentations from Q1 Investor Summit are now available for on-demand viewing. Attendees and investors...

SNANF : 0.3085 (+3.18%)
BRNS : 0.8411 (-3.32%)
FEMY : 0.8500 (-3.41%)
PERF : 2.01 (-0.50%)
DRTS : 2.90 (-0.35%)
GIFT : 1.4900 (+21.14%)
ROYIF : 0.0642 (+163.11%)
ZCAR : 0.5950 (-12.50%)
CLNN : 4.28 (-2.06%)
MIND : 6.59 (+10.20%)
PYPD : 3.28 (-0.91%)
TOVX : 0.4323 (-4.15%)
Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain

FEMY : 0.8500 (-3.41%)

Business Summary

Femasys Inc.is a biomedical company focused on transforming women's healthcare by developing novel solutions as well as providing significant clinical impact to address severely underserved areas. The company's lead product candidates offer FemBloc and FemaSeed. Femasys Inc. is based in ATLANTA.

See More

Key Turning Points

3rd Resistance Point 0.9498
2nd Resistance Point 0.9299
1st Resistance Point 0.8899
Last Price 0.8500
1st Support Level 0.8300
2nd Support Level 0.8101
3rd Support Level 0.7701

See More

52-Week High 1.8000
Fibonacci 61.8% 1.3771
Fibonacci 50% 1.2465
Fibonacci 38.2% 1.1159
Last Price 0.8500
52-Week Low 0.6930

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar